141 related articles for article (PubMed ID: 29592923)
1. Prescribing for ADHD in primary care.
Rashid A; Llanwarne N; Lehman R
Br J Gen Pract; 2018 Apr; 68(669):170-171. PubMed ID: 29592923
[No Abstract] [Full Text] [Related]
2. Prevalence, incidence and persistence of ADHD drug use in Japan.
Okumura Y; Usami M; Okada T; Saito T; Negoro H; Tsujii N; Fujita J; Iida J
Epidemiol Psychiatr Sci; 2019 Dec; 28(6):692-696. PubMed ID: 29804548
[No Abstract] [Full Text] [Related]
3. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
[TBL] [Abstract][Full Text] [Related]
4. Bad Medicine: Psychiatric medicine.
Spence D
Br J Gen Pract; 2018 Dec; 68(677):583. PubMed ID: 30498152
[No Abstract] [Full Text] [Related]
5. ADHD Drug Prescribing Trend Is Increasing Among Children and Adolescents in Hong Kong.
Man KKC; Ip P; Hsia Y; Chan EW; Chui CSL; Lam MPS; Wong WHS; Chow CB; Yung A; Wong ICK
J Atten Disord; 2017 Dec; 21(14):1161-1168. PubMed ID: 24994875
[TBL] [Abstract][Full Text] [Related]
6. Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.
Kornfield R; Watson S; Higashi AS; Conti RM; Dusetzina SB; Garfield CF; Dorsey ER; Huskamp HA; Alexander GC
Psychiatr Serv; 2013 Apr; 64(4):339-46. PubMed ID: 23318985
[TBL] [Abstract][Full Text] [Related]
7. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ
J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
[TBL] [Abstract][Full Text] [Related]
9. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
[TBL] [Abstract][Full Text] [Related]
10. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
Song I; Lee MS; Lee EK; Shin JY
Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 28631372
[TBL] [Abstract][Full Text] [Related]
11. Consequences of ADHD medication use for children's outcomes.
Dalsgaard S; Nielsen HS; Simonsen M
J Health Econ; 2014 Sep; 37():137-51. PubMed ID: 24997381
[TBL] [Abstract][Full Text] [Related]
12. Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence.
Beau-Lejdstrom R; Douglas I; Evans SJ; Smeeth L
BMJ Open; 2016 Jun; 6(6):e010508. PubMed ID: 27297009
[TBL] [Abstract][Full Text] [Related]
13. ADHD Medication Trends in Turkey: 2009-2013.
Öner Ö; Yilmaz EŞ; Karadağ H; Vural M; Vural EH; Akbulat A; Gürsöz H; Türkçapar H; Kerman S
J Atten Disord; 2017 Dec; 21(14):1192-1197. PubMed ID: 24554298
[TBL] [Abstract][Full Text] [Related]
14. Preschool ADHD Diagnosis and Stimulant Use Before and After the 2011 AAP Practice Guideline.
Fiks AG; Ross ME; Mayne SL; Song L; Liu W; Steffes J; McCarn B; Grundmeier RW; Localio AR; Wasserman R
Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940706
[TBL] [Abstract][Full Text] [Related]
15. Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales.
Salmelainen P
N S W Public Health Bull; 2002 Jan; 13 Suppl 1():1-65. PubMed ID: 12189396
[No Abstract] [Full Text] [Related]
16. Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.
Brinker A; Mosholder A; Schech SD; Burgess M; Avigan M
J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):328-33. PubMed ID: 17630866
[TBL] [Abstract][Full Text] [Related]
17. Determinants of inter-practice variation in ADHD diagnosis and stimulant prescribing: cross-sectional database study of a national surveillance network.
Hoang U; James AC; Liyanage H; Jones S; Joy M; Blair M; Rigby M; Lusignan S
BMJ Evid Based Med; 2019 Aug; 24(4):155-161. PubMed ID: 30765384
[TBL] [Abstract][Full Text] [Related]
18. Stimulating: prescribing amidst controversy.
Martin A
Am J Psychiatry; 2006 Apr; 163(4):574-7. PubMed ID: 16585428
[No Abstract] [Full Text] [Related]
19. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.
Pottegård A; Bjerregaard BK; Glintborg D; Kortegaard LS; Hallas J; Moreno SI
Eur J Clin Pharmacol; 2013 Mar; 69(3):589-98. PubMed ID: 22811260
[TBL] [Abstract][Full Text] [Related]
20. Are stimulants overprescribed for youths with ADHD?
Safer DJ
Ann Clin Psychiatry; 2000 Mar; 12(1):55-62. PubMed ID: 10798827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
